Events Search and Views Navigation

Event Views Navigation

Events

Today

  • Mito-race

    Virtual

    Now you can sign up for LHON Eye Society's 5 km Mito-race, either in Stockholm on 15 September, or the virtual one on 12 - 18 September. The event takes place in connection to the World Mitochondrial Disease Week (19 - 25 September).

  • World Mitochondrial Disease Week

    Every year, during the third week of September, the World Mitochondrial Disease Week (WMDW) is being held. This global, important, and rapidly growing event was an initiative from patient organization International mito-patients (IMP).

  • Fireside chat

    Abliva would like to invite interested shareholders and investors to a fun and informal “Fireside Chat” with the company's CEO, Ellen Donnelly, and members of the Abliva team, in Stockholm (28 September) and Lund (29 September). After a long stretch of stringent travel restrictions and two-dimensional zoom presentations, we would like to invite Abliva shareholders […]

  • Mitochondrial Diseases Conference 2021

    Virtual

    Italian patient organization Mitocon arranges this year's Mitochondrial Diseases Conference in virtual. Abliva's Chief Medical Officer, Magnus Hansson, will give a flash presentation and join round table discussions at the meeting.

  • Kvinnokvällen (Women’s night) Malmö

    Virtual

    Abliva will attend Aktiespararna's Kvinnokvällen Malmö, on 19 October 2021.. CEO Ellen Donnelly will be presenting the company at 7:30 p.m. CEST.

  • BioStock Life Science Summit

    Virtual

    Abliva will attend the BioStock Life Science Summit 2021. CEO Ellen Donnelly will be presenting the company on 20 October at 2:00 p.m. CEST.

  • Mitochondrial Medicine – Therapeutic Development

    Virtual

    Abliva will attend the virtual conference Mitochondrial Medicine - Therapeutic Development, organized by the Wellcome Connecting Science located at the Wellcome Genome Campus in the UK, on 30 Nov - 2 Dec 2021. Abliva's CMO, Magnus Hansson, has been invited to give a presentation on the topic Academia-pharma interplay in drug development, during Session 1: Mitochondrial […]

  • Mitochondria-Targeted Drug Development Summit

    Hyatt Regency Boston/Cambridge 575 Memorial Dr, Cambridge, Massachusetts, United States

    Abliva will attend and present at the Mitochondria-Targeted Drug Development Summit in Boston, MA, USA. The event will be held on 22 - 24 February 2022. CEO Ellen Donnelly will be presenting in the session Patient-Focused Drug Development for Mitochondrial Disease. Synopsis: Highlighting the impact of patient input on research and development at Abliva Providing […]

  • Audiocast with teleconference

    Virtual

    Abliva invites to a conference call and an online presentation on June 1, 2022, at 14:00 CEST. Abliva's CEO Ellen Donnelly, CMO Magnus Hansson and CFO Catharina Johansson will inform about the financing and implementation of KL1333 Phase 2/3 study and answer questions. The presentation will be held in English. After the presentation, there will […]

  • UMDF’s Mitochondrial Medicine Symposium

    JW Marriott Phoenix Desert Ridge Resort & Spa Phoenix, AZ, United States

    Abliva will participate at the United Mitochondrial Disease Foundation's Mitochondrial Medicine Symposium in Phoenix, Arizona. Abliva's CMO, Magnus Hansson, will participate in a panel discussion on clinical trials together with Baylor College of Medicine, Cyclerion Therapeutics, and Khondrion, on Friday June 10.

  • Fireside Chat in Lund

    Restaurang Inspira Scheeletorget 1, Lund, Sweden

    In light of our recent announcement and the continued developments in the company, we would like to invite shareholders and interested investors to an informal gathering to hear more about the path forward directly from Ellen Donnelly (CEO) and the Abliva team. We hope you will join us in Lund during the Midsummer week to […]